Cerus Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CERS | INFU | CTSO | AVR | HAE | TMDX | |
|---|---|---|---|---|---|---|
| Market cap | 487.72M | 261.91M | 14.37M | 596.45M | 5.80B | 2.52B |
| P/E (TTM) | — | 32.9 | — | — | 61.6 | 18.8 |
| Forward P/E | -483.0 | 25.3 | — | -5.3 | 22.1 | 32.3 |
| Price/book | 6.4 | 4.4 | -19.1 | 2.4 | 6.9 | 4.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +61.38% | +27.79% | −69.53% | +33.02% | +89.87% | −45.89% |
| Today | +3.21% | +2.73% | +0.44% | +9.29% | +5.94% | +8.04% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All CERS news ›Cerus reaffirms $229M-$231M 2026 product revenue as it now expects CE Mark clearance in late 2027
Cerus Q3 2026 earnings insights: revenue growth, reaffirmed guidance, IFC momentum, and regulatory delays. Earnings Call Insights: Cerus (CERS) Q3 2026 CEO Vivek Jayaraman framed Q3 around growth, innovation, and profitability, saying…
Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells
The primary efficacy endpoint was met, demonstrating non-inferiority for INTERCEPT RBCs compared to conventional RBCs, as measured by adjusted hemoglobin increment, a commonly used measure of RBC transfusion effectiveness1. On a modified…
Cerus' blood-safety system meets main goal in late-stage trial
Cerus’ Intercept technology is designed to reduce the risk of viruses, bacteria and other pathogens in donated blood products. • The late-stage trial met its main goal, showing that Intercept’-treated red blood cells were non-inferior to…
Cerus Corporation (CERS) Q3 2026 Earnings Call Transcript
Cerus Corporation (CERS) Q3 2026 Earnings Call November 2, 2026 4:30 PM EST Timothy Lee - Head of Investor RelationVivek Jayaraman - CEO, President & DirectorKevin Green - VP of Finance & CFO Colin Clark - TD Cowen, Research DivisionMark…
More from 1 other outlet
Cerus GAAP EPS of $0.00 beats by $0.01, revenue of $64M beats by $2.9M
Cerus press release (CERS): Q3 GAAP EPS of $0.00 beats by $0.01. Revenue of $64M (+6.3% Y/Y) beats by $2.9M. Reiterating Full-Year 2026 Product Revenue Guidance - Cerus press release (CERS): Q3 GAAP EPS of $0.00 beats by $0.01. - Revenue…
Cerus May Offer And Sell Up To $150 Million Of Securities From Time To Time - SEC Filing
TradingView Cerus May Offer And Sell Up To $150 Million Of Securities From Time To Time - SEC Filing
Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026
RITZ® Brand Introduces Gluten Free Crackers in Original Flavor Plug Power Appoints Dr. Lee Sweetland as Global Engineering Industrialization Lead Eos Energy Enterprises Announces Preliminary Third Quarter 2026 Revenue Growth and Continued…
Cerus Corporation Closes New Debt Facility of Up to $110 Million
Cerus Corporation announced the closing of a new debt facility with MidCap Financial, providing up to $110 million. The facility consists of a 5-year term loan and an asset-backed revolving loan. The... Cerus Corporation announced the…
Declaration of Voting Results by Cerus Corporation
On June 3, 2026, Cerus Corporation announced that it held its annual general meeting of shareholders on June 2, 2026, and declared the voting results. Accordingly, withhold of William M. Greenman and... Published on 06/03/2026 at 04:18 pm…
Cerus Corporation Signs Four-Year Supply Agreement With Établissement Français Du Sang
Cerus Corporation announced the signing of a new, four-year supply agreement with Établissement Français du Sang, the French Blood Establishment, for the INTERCEPT Blood System. The agreement covers... Cerus Corporation announced the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com13
- seekingalpha.com3
- stocktitan.net1
- themarketsdaily.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.